Opioid	B:C0242402
Use	O
in	O
Chronic	O
Pain	I:C0150055
Patients	O
with	O
Chronic	O
Kidney	I:C1561643
Disease	I:C1561643
:	O
A	O
Systematic	O
Review	I:C1955832
.	O

Opioid	O
Use	O
in	O
Chronic	B:C0150055
Pain	I:C0150055
Patients	O
with	O
Chronic	O
Kidney	I:C1561643
Disease	I:C1561643
:	O
A	O
Systematic	O
Review	I:C1955832
.	O

Opioid	O
Use	O
in	O
Chronic	O
Pain	I:C0150055
Patients	O
with	O
Chronic	B:C1561643
Kidney	I:C1561643
Disease	I:C1561643
:	O
A	O
Systematic	O
Review	I:C1955832
.	O

Opioid	O
Use	O
in	O
Chronic	O
Pain	I:C0150055
Patients	O
with	O
Chronic	O
Kidney	I:C1561643
Disease	I:C1561643
:	O
A	O
Systematic	B:C1955832
Review	I:C1955832
.	O

To	O
investigate	O
the	O
prevalence	O
of	O
chronic	B:C0150055
pain	I:C0150055
and	O
opioid	O
management	O
among	O
patients	O
with	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
(	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
)	O
.	O

To	O
investigate	O
the	O
prevalence	O
of	O
chronic	O
pain	I:C0150055
and	O
opioid	B:C0242402
management	O
among	O
patients	O
with	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
(	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
)	O
.	O

To	O
investigate	O
the	O
prevalence	O
of	O
chronic	O
pain	I:C0150055
and	O
opioid	O
management	B:C1611232
among	O
patients	O
with	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
(	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
)	O
.	O

To	O
investigate	O
the	O
prevalence	O
of	O
chronic	O
pain	I:C0150055
and	O
opioid	O
management	O
among	O
patients	O
with	O
chronic	B:C1561643
kidney	I:C1561643
disease	I:C1561643
(	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
)	O
.	O

To	O
investigate	O
the	O
prevalence	O
of	O
chronic	O
pain	I:C0150055
and	O
opioid	O
management	O
among	O
patients	O
with	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
(	O
chronic	B:C1561643
kidney	I:C1561643
disease	I:C1561643
)	O
.	O

Systematic	B:C1955832
review	I:C1955832
.	O

The	O
review	O
highlights	O
methodological	O
quality	O
assessment	O
of	O
the	O
selected	O
studies	B:C0085973
;	O
prevalence	O
of	O
pain	O
;	O
type	O
,	O
dose	O
,	O
and	O
reason	O
for	O
opioid	O
use	O
;	O
effectiveness	O
of	O
pain	O
control	I:C1304888
and	O
associated	O
adverse	O
effects	I:C0879626
of	O
opioids	O
in	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
patients	O
.	O

The	O
review	O
highlights	O
methodological	O
quality	O
assessment	O
of	O
the	O
selected	O
studies	O
;	O
prevalence	O
of	O
pain	B:C0030193
;	O
type	O
,	O
dose	O
,	O
and	O
reason	O
for	O
opioid	O
use	O
;	O
effectiveness	O
of	O
pain	O
control	I:C1304888
and	O
associated	O
adverse	O
effects	I:C0879626
of	O
opioids	O
in	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
patients	O
.	O

The	O
review	O
highlights	O
methodological	O
quality	O
assessment	O
of	O
the	O
selected	O
studies	O
;	O
prevalence	O
of	O
pain	O
;	O
type	O
,	O
dose	O
,	O
and	O
reason	O
for	O
opioid	B:C0242402
use	O
;	O
effectiveness	O
of	O
pain	O
control	I:C1304888
and	O
associated	O
adverse	O
effects	I:C0879626
of	O
opioids	O
in	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
patients	O
.	O

The	O
review	O
highlights	O
methodological	O
quality	O
assessment	O
of	O
the	O
selected	O
studies	O
;	O
prevalence	O
of	O
pain	O
;	O
type	O
,	O
dose	O
,	O
and	O
reason	O
for	O
opioid	O
use	O
;	O
effectiveness	O
of	O
pain	B:C1304888
control	I:C1304888
and	O
associated	O
adverse	O
effects	I:C0879626
of	O
opioids	O
in	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
patients	O
.	O

The	O
review	O
highlights	O
methodological	O
quality	O
assessment	O
of	O
the	O
selected	O
studies	O
;	O
prevalence	O
of	O
pain	O
;	O
type	O
,	O
dose	O
,	O
and	O
reason	O
for	O
opioid	O
use	O
;	O
effectiveness	O
of	O
pain	O
control	I:C1304888
and	O
associated	O
adverse	B:C0879626
effects	I:C0879626
of	O
opioids	O
in	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
patients	O
.	O

The	O
review	O
highlights	O
methodological	O
quality	O
assessment	O
of	O
the	O
selected	O
studies	O
;	O
prevalence	O
of	O
pain	O
;	O
type	O
,	O
dose	O
,	O
and	O
reason	O
for	O
opioid	O
use	O
;	O
effectiveness	O
of	O
pain	O
control	I:C1304888
and	O
associated	O
adverse	O
effects	I:C0879626
of	O
opioids	B:C0242402
in	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
patients	O
.	O

The	O
review	O
highlights	O
methodological	O
quality	O
assessment	O
of	O
the	O
selected	O
studies	O
;	O
prevalence	O
of	O
pain	O
;	O
type	O
,	O
dose	O
,	O
and	O
reason	O
for	O
opioid	O
use	O
;	O
effectiveness	O
of	O
pain	O
control	I:C1304888
and	O
associated	O
adverse	O
effects	I:C0879626
of	O
opioids	O
in	O
chronic	B:C1561643
kidney	I:C1561643
disease	I:C1561643
patients	O
.	O

There	O
were	O
no	O
randomized	B:C0282440
controlled	I:C0282440
trials	I:C0282440
(	O
randomized	O
controlled	I:C0282440
trials	I:C0282440
)	O
evaluable	O
,	O
and	O
12	O
were	O
observational	O
studies	I:C3658316
.	O

There	O
were	O
no	O
randomized	O
controlled	I:C0282440
trials	I:C0282440
(	O
randomized	B:C0282440
controlled	I:C0282440
trials	I:C0282440
)	O
evaluable	O
,	O
and	O
12	O
were	O
observational	O
studies	I:C3658316
.	O

There	O
were	O
no	O
randomized	O
controlled	I:C0282440
trials	I:C0282440
(	O
randomized	O
controlled	I:C0282440
trials	I:C0282440
)	O
evaluable	O
,	O
and	O
12	O
were	O
observational	B:C3658316
studies	I:C3658316
.	O

Out	O
of	O
12	O
studies	B:C0085973
,	O
four	O
were	O
of	O
high	O
quality	O
,	O
six	O
were	O
of	O
moderate	O
quality	O
,	O
and	O
the	O
remaining	O
two	O
were	O
low	O
-	O
quality	O
studies	O
.	O

Out	O
of	O
12	O
studies	O
,	O
four	O
were	O
of	O
high	O
quality	O
,	O
six	O
were	O
of	O
moderate	O
quality	O
,	O
and	O
the	O
remaining	O
two	O
were	O
low	O
-	O
quality	O
studies	B:C0085973
.	O

The	O
studies	B:C0085973
were	O
from	O
different	O
countries	O
with	O
sample	O
size	O
ranging	O
from	O
10	O
to	O
12,782	O
.	O

The	O
studies	O
were	O
from	O
different	O
countries	B:C0454664
with	O
sample	O
size	O
ranging	O
from	O
10	O
to	O
12,782	O
.	O

Several	O
studies	B:C0085973
showed	O
a	O
high	O
prevalence	O
of	O
chronic	O
uncontrolled	O
pain	I:C0747149
.	O

Several	O
studies	O
showed	O
a	O
high	O
prevalence	O
of	O
chronic	O
uncontrolled	B:C0747149
pain	I:C0747149
.	O

The	O
effectiveness	O
of	O
different	O
categories	O
of	O
opioids	B:C0242402
,	O
dose	O
,	O
duration	O
,	O
and	O
commonly	O
prescribed	O
opioids	O
varied	O
across	O
studies	O
.	O

The	O
effectiveness	O
of	O
different	O
categories	O
of	O
opioids	O
,	O
dose	O
,	O
duration	O
,	O
and	O
commonly	O
prescribed	O
opioids	B:C0242402
varied	O
across	O
studies	O
.	O

The	O
effectiveness	O
of	O
different	O
categories	O
of	O
opioids	O
,	O
dose	O
,	O
duration	O
,	O
and	O
commonly	O
prescribed	O
opioids	O
varied	O
across	O
studies	B:C0085973
.	O

Based	O
on	O
a	O
systematic	B:C1955832
review	I:C1955832
of	O
the	O
current	O
literature	O
,	O
there	O
is	O
fair	O
evidence	O
for	O
the	O
high	O
prevalence	O
of	O
chronic	O
pain	I:C0150055
among	O
patients	O
with	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
,	O
which	O
is	O
not	O
being	O
effectively	O
managed	O
,	O
probably	O
due	O
to	O
underprescription	O
of	O
analgesics	O
or	O
opioids	O
in	O
the	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
population	O
.	O

Based	O
on	O
a	O
systematic	O
review	I:C1955832
of	O
the	O
current	O
literature	O
,	O
there	O
is	O
fair	O
evidence	O
for	O
the	O
high	O
prevalence	O
of	O
chronic	B:C0150055
pain	I:C0150055
among	O
patients	O
with	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
,	O
which	O
is	O
not	O
being	O
effectively	O
managed	O
,	O
probably	O
due	O
to	O
underprescription	O
of	O
analgesics	O
or	O
opioids	O
in	O
the	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
population	O
.	O

Based	O
on	O
a	O
systematic	O
review	I:C1955832
of	O
the	O
current	O
literature	O
,	O
there	O
is	O
fair	O
evidence	O
for	O
the	O
high	O
prevalence	O
of	O
chronic	O
pain	I:C0150055
among	O
patients	O
with	O
chronic	B:C1561643
kidney	I:C1561643
disease	I:C1561643
,	O
which	O
is	O
not	O
being	O
effectively	O
managed	O
,	O
probably	O
due	O
to	O
underprescription	O
of	O
analgesics	O
or	O
opioids	O
in	O
the	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
population	O
.	O

Based	O
on	O
a	O
systematic	O
review	I:C1955832
of	O
the	O
current	O
literature	O
,	O
there	O
is	O
fair	O
evidence	O
for	O
the	O
high	O
prevalence	O
of	O
chronic	O
pain	I:C0150055
among	O
patients	O
with	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
,	O
which	O
is	O
not	O
being	O
effectively	O
managed	O
,	O
probably	O
due	O
to	O
underprescription	O
of	O
analgesics	B:C0002771
or	O
opioids	O
in	O
the	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
population	O
.	O

Based	O
on	O
a	O
systematic	O
review	I:C1955832
of	O
the	O
current	O
literature	O
,	O
there	O
is	O
fair	O
evidence	O
for	O
the	O
high	O
prevalence	O
of	O
chronic	O
pain	I:C0150055
among	O
patients	O
with	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
,	O
which	O
is	O
not	O
being	O
effectively	O
managed	O
,	O
probably	O
due	O
to	O
underprescription	O
of	O
analgesics	O
or	O
opioids	B:C0242402
in	O
the	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
population	O
.	O

Based	O
on	O
a	O
systematic	O
review	I:C1955832
of	O
the	O
current	O
literature	O
,	O
there	O
is	O
fair	O
evidence	O
for	O
the	O
high	O
prevalence	O
of	O
chronic	O
pain	I:C0150055
among	O
patients	O
with	O
chronic	O
kidney	I:C1561643
disease	I:C1561643
,	O
which	O
is	O
not	O
being	O
effectively	O
managed	O
,	O
probably	O
due	O
to	O
underprescription	O
of	O
analgesics	O
or	O
opioids	O
in	O
the	O
chronic	B:C1561643
kidney	I:C1561643
disease	I:C1561643
population	O
.	O

Clinicians	B:C0871685
are	O
in	O
need	O
of	O
additional	O
and	O
well	O
-	O
designed	O
randomized	O
control	I:C0282440
trials	I:C0282440
that	O
focus	O
on	O
the	O
indications	O
for	O
opioid	O
therapy	O
,	O
appropriate	O
opioid	O
doses	O
and	O
dosing	O
intervals	O
,	O
outcomes	O
with	O
adequacy	O
of	O
symptom	O
control	I:C1274136
,	O
and	O
reporting	O
on	O
the	O
incidence	O
of	O
adverse	O
side	I:C0879626
effects	I:C0879626
.	O

Clinicians	O
are	O
in	O
need	O
of	O
additional	O
and	O
well	O
-	O
designed	O
randomized	B:C0282440
control	I:C0282440
trials	I:C0282440
that	O
focus	O
on	O
the	O
indications	O
for	O
opioid	O
therapy	O
,	O
appropriate	O
opioid	O
doses	O
and	O
dosing	O
intervals	O
,	O
outcomes	O
with	O
adequacy	O
of	O
symptom	O
control	I:C1274136
,	O
and	O
reporting	O
on	O
the	O
incidence	O
of	O
adverse	O
side	I:C0879626
effects	I:C0879626
.	O

Clinicians	O
are	O
in	O
need	O
of	O
additional	O
and	O
well	O
-	O
designed	O
randomized	O
control	I:C0282440
trials	I:C0282440
that	O
focus	O
on	O
the	O
indications	O
for	O
opioid	B:C0242402
therapy	O
,	O
appropriate	O
opioid	O
doses	O
and	O
dosing	O
intervals	O
,	O
outcomes	O
with	O
adequacy	O
of	O
symptom	O
control	I:C1274136
,	O
and	O
reporting	O
on	O
the	O
incidence	O
of	O
adverse	O
side	I:C0879626
effects	I:C0879626
.	O

Clinicians	O
are	O
in	O
need	O
of	O
additional	O
and	O
well	O
-	O
designed	O
randomized	O
control	I:C0282440
trials	I:C0282440
that	O
focus	O
on	O
the	O
indications	O
for	O
opioid	O
therapy	B:C0087111
,	O
appropriate	O
opioid	O
doses	O
and	O
dosing	O
intervals	O
,	O
outcomes	O
with	O
adequacy	O
of	O
symptom	O
control	I:C1274136
,	O
and	O
reporting	O
on	O
the	O
incidence	O
of	O
adverse	O
side	I:C0879626
effects	I:C0879626
.	O

Clinicians	O
are	O
in	O
need	O
of	O
additional	O
and	O
well	O
-	O
designed	O
randomized	O
control	I:C0282440
trials	I:C0282440
that	O
focus	O
on	O
the	O
indications	O
for	O
opioid	O
therapy	O
,	O
appropriate	O
opioid	B:C0242402
doses	O
and	O
dosing	O
intervals	O
,	O
outcomes	O
with	O
adequacy	O
of	O
symptom	O
control	I:C1274136
,	O
and	O
reporting	O
on	O
the	O
incidence	O
of	O
adverse	O
side	I:C0879626
effects	I:C0879626
.	O

Clinicians	O
are	O
in	O
need	O
of	O
additional	O
and	O
well	O
-	O
designed	O
randomized	O
control	I:C0282440
trials	I:C0282440
that	O
focus	O
on	O
the	O
indications	O
for	O
opioid	O
therapy	O
,	O
appropriate	O
opioid	O
doses	O
and	O
dosing	O
intervals	O
,	O
outcomes	O
with	O
adequacy	O
of	O
symptom	B:C1274136
control	I:C1274136
,	O
and	O
reporting	O
on	O
the	O
incidence	O
of	O
adverse	O
side	I:C0879626
effects	I:C0879626
.	O

Clinicians	O
are	O
in	O
need	O
of	O
additional	O
and	O
well	O
-	O
designed	O
randomized	O
control	I:C0282440
trials	I:C0282440
that	O
focus	O
on	O
the	O
indications	O
for	O
opioid	O
therapy	O
,	O
appropriate	O
opioid	O
doses	O
and	O
dosing	O
intervals	O
,	O
outcomes	O
with	O
adequacy	O
of	O
symptom	O
control	I:C1274136
,	O
and	O
reporting	O
on	O
the	O
incidence	O
of	O
adverse	B:C0879626
side	I:C0879626
effects	I:C0879626
.	O

